Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc....

From Deciphex on LinkedIn: Our founder and CEO Donal O'Shea was on stage at the International AI Summit in Dublin yesterday, the flagship AI event of Ireland’s EU Council Presidency. He joined Áine Kerr, Dorothy Creaven (Jentic), Eoin...

ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic...

Aiforia® Create 8.0 makes AI model development even faster, smoother, and more intuitive than before. Aiforia Technologies Plc today announces the global market release of Aiforia® Create version 8.0, setting a new industry standard for AI...

OptraSCAN: The whole slide scanner will make its first public appearance at booth 417, following its clearance. Available starting in December. SAN JOSE, CA, UNITED STATES, October 13, 2026 /EINPresswire.com/ -- SAN JOSE, Calif., Oct. 13,...

Proscia: Advances Agilent’s position as a leading pathology solutions provider, with a unique and differentiated combination of instruments, reagents, and software Acquisition seamlessly builds on Agilent’s pathology portfolio expansion...